Primary source: Google Cloud via PR Newswire, November 10, 2026, 8:00 a.m. ET
On November 10, 2026, Google Cloud launched Gemini for healthcare, a preview agent built on the Gemini agent. It is wired to the eligibility, coding, and prior-auth tools a revenue cycle already pays for. Epic and Oracle Health access is read-only. The claim still gets submitted somewhere else. No price was published.
Epic through open.epic APIs, and Oracle Health through Ignite APIs for FHIR. The release says the connection pulls the chart without writing back. NextGen is in development.
The press release is datelined Sunnyvale and timed at 8:00 a.m. ET. Google calls the product a purpose-built agentic solution for clinical, operational, and administrative work, on the provider side and on the health-plan side. Launch customers named in the release are Blue Cross Blue Shield of Massachusetts, Hartford HealthCare, HCA Healthcare, Highmark Health, Northwell Health, Optum, and Stanford School of Medicine. The American Society of Clinical Oncology is named as a contributor, not as a customer. Thomas Kurian's Google Cloud blog post the same day says the preview is available in the United States.
This is not Gemini Health Partners. That firm is a different company, and the October 8 article is about its advisory practice. The earlier Google Health profile is a company review. Today's story is the product launch.
| Piece | What Google said on November 10 |
|---|---|
| Skills | The release and Kurian's post name medical records synthesis, pre-appointment preparation, coverage and policy review, and payer benefit determination. Organizations can add their own. |
| EHR | Read access to Epic through open.epic APIs and to Oracle Health through Ignite APIs for FHIR. The release says teams can pull conditions, medications, and recent labs "without writing back to the EHR to safeguard clinical data integrity." Kurian's post says both EHRs are read-only, with no write-back to the chart. NextGen connectivity is in development and, in the release, "slated for release in the coming months." |
| Other clinical pipes | InterSystems FHIR Server. Keragon, which the release says reaches over 400 healthcare applications. Verato for patient identity across visits and sources. |
| Coding lookups | CMS Coverage Data, the NPI Registry, RxNorm, ICD-10, and IMO Health's Knowledge Graph. The release says those lookups support coding accuracy. Kurian's post says CMS Coverage means current Medicare National and Local Coverage Determinations, not a static copy in the model. |
| Eligibility | Optum Network Eligibility and Coordination of Benefits, which both the release and the Cloud blog say are in limited release and testing. The press release names Waystar for eligibility verification and payment source-of-truth. Cognizant TriZetto verifies eligibility and network coverage in the release. Kurian's post names TriZetto Provider Solutions for eligibility, coverage, co-pays, and deductibles across Medicare, Medicaid, and major commercial plans, and that connector section does not repeat Waystar. |
| Prior auth and appeals | Infinitus Relay. The release says it automates benefit verification and supports prior authorization workflows. The Cloud blog says it automates the payer phone calls those two jobs require. UiPath, in the release, extracts citation-backed evidence for utilization reviews and appeals. The Cloud blog also names prior authorizations. |
| Drug price | GoodRx, for prescription pricing and savings. The Cloud blog adds manufacturer-sponsored self-pay programs. |
| What Gemini costs | Not disclosed. The release says buyers can choose per-user seat subscriptions or pay-as-you-go, and that the product is for Gemini Enterprise Standard and Gemini Enterprise Plus customers. No dollar figure in the release, the Cloud blog, Fortune, or AuxoAI's partner release. |
This is RevCycleAI's read. Google is not standing up a new clearinghouse this morning. It is offering to sit on top of the vendors that already check eligibility, look up a benefit, call a payer, and pull chart evidence for an appeal.
If you run the billing shop, sort the work by who can touch the record. On these posts, Gemini can read Epic and Oracle Health. It can ask Optum, TriZetto, and, in the press release, Waystar what the coverage is. Optum's eligibility and coordination-of-benefits connectors are in limited release and testing, so they are not the general path. Infinitus is the phone call for benefit verification and prior auth. UiPath is the evidence pack for utilization review and appeals. The coding step is a lookup against CMS coverage, NPI, RxNorm, ICD-10, and IMO. That is a reference check. It is not a statement that a coder has been removed from the account.
Write-back is the line that decides whether this changes the claim. A read-only chart means a person, or a system that is allowed to write, still updates the EHR, still drops the charge, and still submits. Kurian's post says the provider skill assembles an authorization packet against payer policy before submission, "so fewer claims come back denied." The "so" is the aim. Neither Google post publishes a denial rate, a cost to collect, or a cash yield for any launch customer.
"The real promise of AI in healthcare isn't simply doing today's work faster. It's creating a better way for the health system to work. When payers and providers can connect data, insights and workflows more seamlessly, we can remove unnecessary complexity, improve performance and help the entire system work better." — Sandeep Dadlani, chief executive officer, Optum Insight, in the Google Cloud release and on the Cloud blog.
Optum is on both sides of the launch. It is a named customer, and its eligibility connectors are the ones Google says are still in testing. Dadlani runs Optum Insight. The same morning, a separate NSE filing described certain client contracts from a segment of that ambulatory business moving into a company IKS bought for USD 500,000. The Gemini release does not describe a sale. The filing does not describe this product. They stay two stories.
Fortune, the same morning, interviewed John D'Angelo, Northwell's chief executive. He told Fortune he has about 400 employees whose sole job is fighting insurance denials, that Northwell overturns over 90% of them, and that the system is "a 1% margin business at best." Those are his figures for Northwell's denial shop. They are not a Gemini result, and they are not in the product release. They are why a launch customer cares about an agent that can read a chart and a policy. The release's own D'Angelo quote is the shorter line about time back for patients.
Gemini for healthcare is in preview. On these documents it does not write back to Epic or Oracle Health, it does not submit a claim, and it does not carry a price. The "nearly 28 hours" a week on documentation is a Harris Poll and Google Cloud study the release cites. The 41.9% physician-burnout figure is a 2025 American Medical Association report the release cites. The 25% to 35% administrative-cost share is an American Hospital Association estimate the release cites. None of those is an outcome of this product. AuxoAI's release at 8:05 a.m. ET says it is a launch partner and that it plans to help joint customers on prior authorization, utilization management, claims operations, and provider revenue cycle. A plan is not a workflow already running in the practice management system.
Three items decide whether this is a new front end on tools you already own, or the start of those tools getting routed around.
The fee. Seat versus pay-as-you-go is a shape, not a number. Until Google or a customer prints a price, you cannot set it next to a Waystar eligibility transaction, a TriZetto lookup, or an Infinitus call. Waystar is the vendor the press release names for eligibility and for "payment source-of-truth." Kurian's connector section lists Optum, TriZetto, GoodRx, and Infinitus in that block and does not repeat Waystar. Use the press release for the Waystar sentence, and ask which customers actually have the connector.
Write-back. The day an agent can update the chart or drop a claim, it stops being a reader and starts competing with the system of record. The release draws that line on purpose. Watch whether it moves. NextGen is the sequencing tell: the release says that connector is still in development.
Who stays a connector. A hyperscaler that can assemble an auth packet, check a benefit, and draft an appeal from the chart does not have to buy Waystar, Optum, TriZetto, or Infinitus to sit in front of them. The vendor that still writes, submits, and holds the payment file stays in the stack. The vendor whose job was to put the same data on a screen for a person is the one this design can hollow out. Google has not sorted that list. The renewal is where it gets sorted.
Google is moving into the payer and provider admin layer by orchestrating RCM vendors you already run, in preview, on a read-only chart. The claim still lives in the system that can write one. No price was disclosed.
Treat this as a front end until a contract says otherwise. Eligibility, coding lookups, benefit determination, and prior-auth evidence, hung off an agent that is not allowed to write the EHR, is useful when the connector is actually on in your instance. It is a demo where Optum's eligibility piece is still in testing, and where Waystar is a sentence in the release that the Cloud blog's connector list does not repeat.
The open items are the fee, the write-back, and which of those vendors keep the submit. Do not budget a displacement off a preview.
Who can read the chart, who can write the claim, and what is still in testing.
Sources: Google Cloud via PR Newswire, "Google Cloud Launches Gemini for Healthcare," November 10, 2026, 8:00 a.m. ET, Sunnyvale; Thomas Kurian, "Introducing Gemini for healthcare," Google Cloud Blog, November 10, 2026; Google blog, "Google Cloud launches Gemini for healthcare," November 10, 2026; Fortune, Catherina Gioino, November 10, 2026, 8:00 a.m. ET (D'Angelo interview: about 400 denial-fighting employees, overturns over 90%, "a 1% margin business at best"); AuxoAI via PR Newswire, November 10, 2026, 8:05 a.m. ET. Dadlani's quotation is verbatim from the Google Cloud release. The 28-hour, 41.9%, and 25% to 35% figures are the studies the release cites, not product results. No Gemini price was disclosed, and none is estimated.